|
|
||||||||
From the Laboratory of Ocular Pharmacology and Physiology, University Eye Clinic Basel, Basel, Switzerland.
PURPOSE. To investigate adrenomedullin-induced relaxation in isolated porcine ciliary arteries.
METHODS. In a myograph system (isometric force measurement), precontracted vessels (
0.1 µM U46619; thromboxane A2 analogue or
10 nM endothelin-1) were exposed, in a cumulative manner, to increasing concentrations of adrenomedullin (1 nM to 1 µM) in the presence or absence of different drugs. Some experiments were conducted in vessels with nonfunctional (intentionally mechanically damaged) endothelium.
RESULTS. Adrenomedullin evoked marked relaxation [maximum relaxation (Relmax): 85.5 ± 3.0%; negative log M concentration inducing 50% of Relmax (pD2): 7.4 ± 0.1] in comparison to time-controls (Relmax: 19.2 ±4.8%; P < 0.001). Relaxation was inhibited by 3 µM CGRP[8-37] (CGRP1 receptor antagonist; Relmax: 27.2% ± 5.3%; P < 0.001) but not by 3 µM adrenomedullin[22-52] (presumed adrenomedullin receptor antagonist; P = 0.75). Adrenomedullin-induced relaxation was less pronounced in nonfunctional endothelium vessels (Relmax: 67.6% ± 3.1%; pD2: 6.9 ± 0.1; P < 0.01). In vessels with functional endothelium, relaxation was not significantly influenced by 0.1 mM NG-nitro-L-arginine methyl ester (L-NAME; a nitric oxide synthesis inhibitor), 10 µM indomethacin (a cyclooxygenase inhibitor), or 10 µM 17-octadecynoic acid (a cytochrome P450 inhibitor). In contrast, relaxation was significantly inhibited by either 10 mM tetraethylammonium (nonselective potassium channel inhibitor; P < 0.01) or 50 nM apamin (small conductance potassium channel inhibitor), together with 50 nM charybdotoxin (large and intermediate potassium channel inhibitor; P < 0.01). In the presence of these potassium channel inhibitors, the amount of relaxation was not significantly different (P > 0.50) from that observed in vessels with nonfunctional endothelium.
CONCLUSIONS. In isolated porcine ciliary arteries, adrenomedullin induces relaxation that involves CGRP1 receptors and is in part endothelium dependent. Endothelium-dependent relaxation was blocked by some potassium channel inhibitors, suggesting the possible release of an endothelium-derived hyperpolarizing factor (EDHF).
This article has been cited by other articles:
![]() |
I. Vysniauskiene, R. Allemann, J. Flammer, and I. O. Haefliger Vasoactive Responses of U46619, PGF2{alpha}, Latanoprost, and Travoprost in Isolated Porcine Ciliary Arteries Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 295 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Cleary, C H Buckley, E Henry, P McLoughlin, C O'Brien, and P W F Hadoke Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye Br J Ophthalmol, February 1, 2005; 89(2): 223 - 228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |